Drug Hypersensitivity, An Issue of Immunology and Allergy Clinics of North America
- 1st Edition, Volume 42-2 - April 27, 2022
- Latest edition
- Editor: Elizabeth Phillips
- Language: English
In this issue of Immunology & Allergy Clinics, guest editor Dr. Elizabeth J. Phillips brings her considerable expertise to the topic of Drug Hypersensitivity. Top experts i… Read more
Purchase options
In this issue of Immunology & Allergy Clinics, guest editor Dr. Elizabeth J. Phillips brings her considerable expertise to the topic of Drug Hypersensitivity. Top experts in the field cover key topics such as perioperative anaphylaxis; telemedicine in drug hypersensitivity; aspirin-exacerbated respiratory disease; pediatric drug allergy; and more.
-
Contains 15 relevant, practice-oriented topics including excipient allergy; recognizing drug hypersensitivity in skin of color; allergy to radiocontrast dye; MRGRPX2 and its role in non-IgE-mediated mast cell activation; and more.
-
Provides in-depth clinical reviews on drug hypersensitivity, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Recognizing Drug Hypersensitivity in Pigmented Skin
Anaphylaxis to Excipients in Current Clinical Practice: Evaluation and Management
Mas-Related G Protein–Coupled Receptor-X2 and Its Role in Non-immunoglobulin E– Mediated Drug Hypersensitivity
Hypersensitivity Reactions and Immune-Related Adverse Events to Immune Checkpoint Inhibitors: Approaches, Mechanisms, and Models
Skin Testing Approaches for Immediate and Delayed Hypersensitivity Reactions
Telemedicine in Drug Hypersensitivity
Pharmacogenomics of Drug Hypersensitivity: Technology and Translation
Advances in the Pathomechanisms of Delayed Drug Hypersensitivity
A Risk-Based Approach to Penicillin Allergy
Allergy to Radiocontrast Dye
The Who, What, Where, When, Why, and How of Drug Desensitization
Aspirin-Exacerbated Respiratory Disease: A Unique Case of Drug Hypersensitivity
Pediatric Drug Allergy
The Use of Electronic Health Records to Study Drug-Induced Hypersensitivity Reactions from 2000 to 2021: A Systematic Review
Anaphylaxis to Excipients in Current Clinical Practice: Evaluation and Management
Mas-Related G Protein–Coupled Receptor-X2 and Its Role in Non-immunoglobulin E– Mediated Drug Hypersensitivity
Hypersensitivity Reactions and Immune-Related Adverse Events to Immune Checkpoint Inhibitors: Approaches, Mechanisms, and Models
Skin Testing Approaches for Immediate and Delayed Hypersensitivity Reactions
Telemedicine in Drug Hypersensitivity
Pharmacogenomics of Drug Hypersensitivity: Technology and Translation
Advances in the Pathomechanisms of Delayed Drug Hypersensitivity
A Risk-Based Approach to Penicillin Allergy
Allergy to Radiocontrast Dye
The Who, What, Where, When, Why, and How of Drug Desensitization
Aspirin-Exacerbated Respiratory Disease: A Unique Case of Drug Hypersensitivity
Pediatric Drug Allergy
The Use of Electronic Health Records to Study Drug-Induced Hypersensitivity Reactions from 2000 to 2021: A Systematic Review
- Edition: 1
- Latest edition
- Volume: 42-2
- Published: April 27, 2022
- Language: English
EP
Elizabeth Phillips
Affiliations and expertise
John A. Oates Chair in Clinical Research
Professor of Pathology, Microbiology and Immunology
Professor of Pharmacology
Professor, Department of Medicine, Division of Infectious Diseases
Vanderbilt University Medical Center
Nashville, Tennessee USA